Associations between gastrointestinal toxicity, micro RNA and cytokine production in patients undergoing myeloablative allogeneic stem cell transplantation
Authors:
- Peter L. PontoppidanPPPeter L. Pontoppidan
- Hilde Hylland UhlvingHUHilde Hylland Uhlving
- Katrine KielsenKKKatrine Kielsen
- Mette ChristensenMCMette Christensen
- Marianne IfversenMIMarianne Ifversen
- Claus Henrik NielsenCNClaus Henrik Nielsen
- Per SangildPSPer Sangild
- Carsten HeilmannCHCarsten Heilmann
- Henrik SengeløvHSHenrik Sengeløv
- 1 March 2015
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 25 (1) , 180-188
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- MicroRNA‐146 represses endothelial activation by inhibiting pro‐inflammatory pathwaysEMBO Molecular Medicine, 2013
- Circulating MicroRNA Expression Profiles Associated With Systemic Lupus ErythematosusArthritis & Rheumatism, 2013
- The IL-17 Differentiation Pathway and Its Role in Transplant OutcomeTransplantation and Cellular Therapy, 2012
- MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritisProceedings of the National Academy of Sciences, 2011
- MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseasesTranslational Research, 2011
- MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell DevelopmentImmunity, 2010
- microRNAs and the immune responseCurrent Opinion in Pharmacology, 2009
- Graft-versus-host diseaseThe Lancet, 2009
- MicroRNA Control in the Immune System: Basic PrinciplesCell, 2009
- NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesProceedings of the National Academy of Sciences, 2006